IS
Islet Sciences, Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Perlin Joel, was filed 17 May 2012.
Islet Sciences, Inc: what insiders have been doing
Islet Sciences, Inc is a listed company. Its directors and officers file their transactions with SEC (Form 4). No insider at Islet Sciences, Inc has published a filing in the past twelve months. The most recent one dates from 26 June 2012.
The full history, which starts in 2012, counts 2 purchases against no sales.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
8
Thresholds
n/a
Buy Volume
€37,795
2 ops. · all time
Sell Volume
n/a
n/a
Last declaration on 26 June 2012
Declarations8 total
- 7,366,668 sharesCommon stockSEC:0001532197-12-000004:0
- 200,000 sharesCommon stockSEC:0001532197-12-000004:1
- 866,668 sharesCommon stockSEC:0001532197-12-000004:2
- 50,000 sharesCommon stockSEC:0001540741-12-000002:0
- 50,000 sharesCommon stockSEC:0001540741-12-000002:1
- 150,000 sharesCommon stockSEC:0001540741-12-000002:2
- 240,000 sharesCommon stockSEC:0001539975-12-000002:0Canonical exit: 7 Aug 2012 (T+90)
- 111,111 shares@ US$0.45Common stockSEC:0001541219-12-000003:0Canonical exit: 18 Jun 2012 (T+90)
8 of 8 declarations
About Islet Sciences, Inc
Islet Sciences, Inc is a company focused on developing therapies for diabetes treatment. It concentrates on innovative solutions to improve the management of this disease.
